---
title: Defining a clinical strategy in oncology
description: Defining a clinical strategy in oncology
---

[Case Studies Archive - Alacrita ](https://www.alacrita.com/case-studies)

# [Defining a clinical strategy in oncology](https://www.alacrita.com/case-studies/defining-clinical-strategy-oncology)

 Written by [John Simpson](https://www.alacrita.com/case-studies/author/john-simpson) | Feb 7, 2017 1:13:24 PM

## Challenge:

A venture capital-backed platform technology company wanted to develop its internal pipeline of therapeutic oncology candidates, while allowing prospective partners to access the technology platform through selected R&D collaborations. Alacrita was asked to help create a detailed early clinical plan for the company's lead asset, to be used as a foundation piece of the business strategy.

## Solution:

Our oncology consultant created a detailed timeline and gap analysis for the company’s initial IND filing and Phase 0-l clinical trial launch, which involved the below.

- reviewing relevant documents, including the technology; pre-existing corporate, scientific, and clinical goals; and any preclinical data
- holding interviews with key stakeholders including company founders, the CEO and the internal R&D team
- reviewing potential target cancer indications and establishing up-to-date standards of care
- reviewing relevant biomarkers to inform PK/PD activity and patient enrichment strategies
- preparing a clinical development plan including prioritization of target indications, design of Phase 0-lla clinical trials and proposal for clinical trial investigators and sites
- developing an interval-to-IND filing gap analysis.

Our consultant presented to the Board and was retained as an ongoing medical advisor to the company.

[View full post](https://www.alacrita.com/case-studies/defining-clinical-strategy-oncology)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "John Simpson"
  },
  "dateModified" : "2021-04-06T15:36:13.502Z",
  "datePublished" : "2017-02-07T13:13:24Z",
  "headline" : "Defining a clinical strategy in oncology",
  "image" : {
    "@type" : "ImageObject",
    "height" : 711,
    "url" : "https://cdn2.hubspot.net/hubfs/3828687/Alacrita_April2019/Images/alacrita_how_we_can_help_clinical_development.jpg",
    "width" : 2000
  },
  "mainEntityOfPage" : "https://www.alacrita.com/case-studies/defining-clinical-strategy-oncology",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "Case Studies"
  }
}
```